Johnson & Johnson Covid-19 vaccine study paused due to illness
Clinical trial pauses are not uncommon, but they are generating outsized attention in the race to test Covid-19 vaccines.
STAT
141d ago
BREAKING: Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
853
BREAKING: Johnson & Johnson’s #COVID19 vaccine trial of 60,000 has been suddenly paused due to a new unexplained illness. Study enrollment website also frozen while DSMB (data safety monitoring board) reviews. to be updated.
The Phase 3 trial for Johnson & Johnson's #Covid19 vaccine has been paused while researchers look into an unexpected illness that occurred in one of the participants, @matthewherper reports. J&J would release no information on what the illness was.
EXCLUSIVE: Johnson & Johnson #COVID19 vaccine study paused due to unexplained illness in participant statnews.com/2020/10/12/joh… via @statnews @matthewherper
Vaccine trials are working! And by that I mean, due diligence is being done. Safety signals are being monitored.
To some, this will feel like crashing into a wall. But these pauses are routine and part of the process. Stop, investigate, start again.
BREAKING: Johnson & Johnson #COVID19 vaccine study paused due to unexplained illness in participant statnews.com/2020/10/12/joh… via @matthewherper $JNJ
🚨BREAKING: huge clinical trial of Johnson & Johnson’s #coronavirus vaccine has been paused with enrollment of new participants stopped due to an "unexplained illness" in a study participant.
No details yet on the nature of the potential adverse reaction.
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant $JNJ
Stat News: Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
Just now via @statnews and @matthewherper, @JNJNews #COVID19 vaccine study is on hold due to an “unexplained illness” in a participant LINK: statnews.com/2020/10/12/joh… pic.twitter.com/w4VRGHVl0w
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant statnews.com/2020/10/12/joh… @matthewherper #COVID19
A pause. Not unexpected but still frustrating. Not even clear yet whether the single adverse event is in treatment or control group. This is why it's good to have multiple shots on goal.
Johnson & Johnson Covid-19 vaccine study paused due to illness. Another vaccine trial on hold.
This is hard.
Johnson & Johnson Covid-19 vaccine study paused due to illness, @matthewherper reports
@MattHerper report: J&J Covid-19 vaccine study paused due to illness. Nature of the illness is not yet public. This is a 60,000 patient study started 9/23/20. The AstraZeneca/Oxford vaccine trial remains paused in the US.
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant statnews.com/2020/10/12/joh… via @statnews
J&J's #Covid19 #vaccine study paused due to unexplained illness in participant - A document sent to outside researchers running the 60,000-patient trial states that a “pausing rule” has been met, & online enrollment has been closed... statnews.com/2020/10/12/joh… via @statnews
It’s reassuring that trials continue to be done with care> Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant statnews.com/2020/10/12/joh… via @statnews
The DSMB will determine the impact of the observed adverse event on the @JNJNews #COVID19 vaccine trial. Timely reporting by @matthewherper
11.
- Johnson & Johnson, who started their phase 3 clinical trial on 9/23/20, paused earlier this month and was also cleared by the FDA to restart on Friday, 10/23/20.
Archive: web.archive.org/web/2020101301…
statnews.com/2020/10/12/joh…